Druck Icon

Eckert & Ziegler acquires nuclitec

(Ad hoc press release)

Berlin, 23.1.2009 - The Berlin based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) has exercised its option acquired in December 2008 and taken over all shares of the Braunschweig, Germany, based company nuclitec GmbH and its French and US based sister companies nuclitec sarl and nuclitec Inc. (together see: www.nuclitec.com). The purchase price agreed on for the companies and for the cash reserves remaining in the companies was 6.6 million EUR. A capital increase is currently being implemented to partly finance the transaction.

The long-established isotope specialist nuclitec used to trade under the names of QSA Global GmbH and QSA Global sarl and counts worldwide among the most established companies in the sector. It has been producing radioactive components for the medical and measurement engineering field for over 30 years. In the last fiscal year that ended on 31.3.2008, the turnover amounted to 23.1 million EUR. About 120 employees thereby achieved an approximately balanced result (plus 0.1 million EUR).

Dr. Andreas Eckert, CEO of Eckert & Ziegler, commented: "nuclitec and Eckert & Ziegler complement each other perfectly. They have considerable synergy potential when manufacturing and selling isotope components for industrial, scientific and medical applications. In order to increase profitability, we will during the next months need to implement a number of structural changes, but Braunschweig itself as a production site will remain. We look forward to welcome the talents and the experience that the nuclitec staff brings to our group. Also, we are excited about the interesting future fields of activity that nuclitec will contribute, in particular the clean-room manufacturing of the radiopharmaceutical Yttrium-90 and the environmental services."

The Board of Directors